News
Exploring the real and potential impact of Generative AI on medicine and healthcare
Dr. Serag chaired the Generative AI Panel at BioTechX Europe 2023 in Basel, Switzerland. Generative AI in medicine holds the potential to revolutionize drug discovery, medical imaging, and personalized treatment by generating novel compounds, improving diagnostic accuracy, and tailoring therapies to individual patients.
|
Towards General AI in Medicine
Dr Serag was invited to speak at the Drug Discovery Innovation Programme (DDIP) in Barcelona, Spain. He discussed the path to building general AI in Medicine, and shared his insights on the limitations of current machine learning and what lies ahead.
|
AI R&D Commercialisation
Dr. Serag took the stage as the keynote speaker at the AI Accelerator Summit in San Jose, delivering a compelling address on the transformative potential of AI in healthcare. During his keynote, he highlighted the challenges of AI research and development commercialization and its seamless integration into the healthcare industry. Dr. Serag emphasized the importance of overcoming these obstacles to fully unlock the vast capabilities of AI in enhancing healthcare outcomes and patient well-being.
|
The role of AI in Medicine
At Weill Cornell Medicine - Qatar, Dr. Serag delivered an engaging presentation on the significant role of Artificial Intelligence (AI) in Medicine. Through his talk, he delved into the multifaceted applications of AI, exploring how these cutting-edge technologies can revolutionize healthcare practices across various domains, from medical imaging and diagnosis to personalized treatment plans.
|
AI Innovation in Healthcare: Making the Invisible Visible
Dr. Serag presented at the AI Accelerator Festival, discussing the pivotal role of AI Innovation and Data Science in the future of Healthcare. His talk showcased how AI-based systems are already transforming diagnostic accuracy and treatment efficiency in healthcare and medicine. Dr. Serag emphasized the potential of advanced data processing technologies to reveal previously unseen complexities, such as recognizing complex tumors, diseases, and intricate changes. The engaging presentation covered the latest AI innovations in various medical specializations and explored the significant challenges in adopting AI technologies within the healthcare industry.
|
Accelerating the Development of AI Algorithms
Dr. Serag had the privilege of presenting at the esteemed Royal College of Pathologists in London, UK. His talk centered around the innovative use of Generative AI technologies such as generative adversarial networks (GANs) for anomaly detection in histopathology images. The audience was engaged as he discussed the potential impact of these AI techniques in pathology, offering improved accuracy and timely anomaly identification for enhanced diagnostics and patient care. The presentation sparked valuable discussions, fostering further exploration of AI applications in pathology.
|
AI Applications in Healthcare
Dr. Serag delivered an insightful talk on how AI is enhancing healthcare delivery at the Business Intelligence, Analytics, and Data Management Summit in Vienna, Austria. His presentation shed light on the transformative potential of AI technologies in improving healthcare delivery processes, from streamlining patient care to enhancing medical diagnoses.
|
Unsupervised Anomaly Detection in Digital Pathology Images
Dr. Serag presented latest research on unsupervised anomaly detection using generative adversarial networks (GANs) at the Computational Pathology Symposium of the European Congress of Pathology in Nice, France. The audience showed great interest in our work, and the symposium provided an excellent platform to share insights into how GANs can revolutionize anomaly detection in pathology, potentially enhancing diagnostic accuracy and patient care.
|
Using Artificial Intelligence in Biomedicine in Academia and Industry
Dr. Serag had the honor of being invited by the Max Planck Institute to deliver a talk on the use of Artificial Intelligence (AI) in biomedicine in academia and industry. The event provided a valuable platform to inspire fellow researchers and scholars, offering insights into the seamless integration of AI in both academic and industrial settings, and how interdisciplinary collaborations can drive meaningful contributions to scientific advancements in biomedicine. During the event, he shared career lessons as a researcher across disciplines and continents.
|
AI & Deep Learning for Cancer Detection
During the Deep Learning in Healthcare Summit in London, UK, Dr. Serag delivered a talk on AI & Deep Learning for Cancer Detection. The presentation focused on the transformative potential of AI and deep learning in improving cancer detection methods, leading to earlier and more accurate diagnoses. The audience engaged with the innovative applications of these technologies, and we explored how AI-driven approaches can revolutionize cancer care, ultimately enhancing patient outcomes and saving lives.
|